参考文献/References:
[1]Henderson J T,Thompson J H, Burda B U,et al. Preeclampsia screening [J].JAMA,2017,317(16):1668-1685.
[2]Schiff E, Friedman S A,Sibai B M.Conservative management of severe preeclampsia remote from term[J].American Jourral of Obsterics & Gynecology,2013,209(5):425.
[3]ADANE A A, MISHRA G D, TOOTH L R. Adult Pre-pregnancy Weight Change and Risk of Developing Hypertensive Disorders in Pregnancy [J]. Paediatric and Perinatal Epidemiology, 2017, 31 (3): 167-175.
[4]LIU Jia, LIU Jia-mei, SHI Lin-ying, et al. Preliminary study of microRNA-126 as a novel therapeutic target for primary hypertension [J]. International Journal of Molecular Medicine, 2018, 41 (4): 1835-1844.
[5]DENG L, BRADSHAW A C, BAKER A H. Role of noncoding RNA in vascular remodeling [J]. Current Opinion in Lipidology, 2016, 27 (5): 439.
[6]PANCHAPAKESAN U, POLLOCK C. Long non-coding RNAs - towards precision medicine in diabetic kidney disease? [J]. Clinical Science, 2016, 130 (18): 1599-1602.
[7]MEMCZAK S, JENS M, ELEFSINIOTI A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency [J]. Nature, 2013, 495 (7441): 333-338.
[8]HSIAO K Y, SUN H-s, TSAI S J. Circular RNA–new member of noncoding RNA with novel functions [J]. Experimental Biology and Medicine, 2017, 242 (11): 1136.
[9]MEMCZAK S, PAPAVASILEIOU P, PETERS O A. Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood [J]. PLOS One, 2015, 10 (10): e0141214.
[10]Tan L, Yu JT, Hu N, et al. Non-coding RNAs in Alzheimer's disease [J]. Mol Neurobiol, 2013, 47 (1):382-393.
[11]BURD C E, JECK W R, LIU Yan, et al. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk[J]. PLOS Genetics, 2010, 6(12): e1001233.
[12]XIA Tian, LIAO Qi, JIANG Xiao-ming, et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer [J]. Scientific Reports, 2014, 4: 6088.
[13]HANSEN T B, JENSEN T I, CLAUSEN B H, et al. Natural RNA circles function as efcient microRNA sponges [J]. Nature, 2013, 495(7441): 384–388.
[14]HANSEN T B, KJEMS J, DAMGAARD C K. Circular RNA and miR-7 in cancer [J]. Cancer Research, 2013, 73(18): 5609-5612.
[15]DACHEW B A, MAMUN A, MARAVILLA J C, et al. Association between hypertensive disorders of pregnancy and the development of offspring mental and behavioural problems: A systematic review and meta-analysis [J]. Psychiatry Research, 2018, 260 (2): 458-467.
[16]HOFMEYR G J, ATALLAH A N, DULEY L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems [J]. Cochrane Database of Systematic Reviews, 2006, 1 (3): CD001059.
[17]LUITJES S H, WOUTERS M G, KONIG T, et al. Hypertensive disorders in pregnancy: a review of international guidelines [J]. Hypertension in Pregnancy, 2013, 32 (4): 367-377.
[18]CAIRNS A E, TUCKER K L, LEESON P A, et al. Survey of healthcare professionals regarding adjustment of antihypertensive medication(s) in the postnatal period in women with hypertensive disorders of pregnancy [J]. Pregnancy Hypertension: an International Journal of Women's Cardiovascular Health, 2016, 6 (4): 256-258.
[19]SALZMAN J, GAWAD C, WANG P L, et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types [J]. PLOS One, 2012, 7 (2): e30733.
[20]LI Yan, ZHENG Qiu-peng, BAO Chun-yang, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis [J]. Cell Research, 2015, 25 (8): 981-984.
[21]RYBAK-WOLF A, STOTTMEISTER C, GLAZAR P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed [J]. Molecular Cell, 2015, 58 (5): 870-885.
[22]HOFFMANN S, OTTO C, DOOSE G, et al. A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection [J]. Genome Biology, 2014, 15 (2): R34.
[23]CONN S J, PILLMAN K A, TOUBIA J, et al. The RNA binding protein quaking regulates formation of circRNAs [J]. Cell, 2015, 160 (6): 1125-1134.
[24]MEMCZAK S, JENS M, ELEFSINIOTI A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency [J]. Nature, 2013, 495 (7441): 333-338.
相似文献/References:
[1]黄辉秀,谭毅.妊娠期高血压疾病预测和预防的研究现状[J].中国计划生育和妇产科,2009,(05):0.
HUANG Hui-xiu,TAN Yi MCH Hospital of Fangcheng urban district,Fangchenggang city Guangxi automous region 80,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(8):0.
[2]张珺,仲红丽.妊娠期高血压疾病监测系统预测及早期干预520例临床分析[J].中国计划生育和妇产科,2009,(06):0.
[3]肖兵,高岩,熊庆,等.妊娠期高血压疾病的流行病学研究进展[J].中国计划生育和妇产科,2010,(01):0.
[4]何怡,赵可文,唐莉,等.卡孕栓防治妊娠期高血压疾病产后出血的疗效观察[J].中国计划生育和妇产科,2010,(02):0.
HE Yi,ZHAO Ke-wen,TANG LiMCH hospital of Dongguan city,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(8):0.
[5]庞春蓉,傅晓冬.肾上腺髓质素与妊娠期高血压疾病[J].中国计划生育和妇产科,2010,(02):0.
[6]陈倩,段成城,傅晓冬,等.血清T辅助细胞比率与妊娠期高血压疾病的关系和意义[J].中国计划生育和妇产科,2010,(03):0.
CHEN Qian,DUAN Cheng-cheng,FU Xiao-dong..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(8):0.
[7]陈茜松,刘丽俊,季淑英,等.妊娠期高血压疾病患者血清抵抗素水平的变化及其临床意义[J].中国计划生育和妇产科,2011,(03):0.
CHEN Qian-song,LIU Li-jun,JI Shu-ying.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.
[8]侯卫萍,程兰,黄立,等.血清胱抑素C在妊娠期高血压疾病中的应用[J].中国计划生育和妇产科,2011,(06):0.
HOU Wei-ping,CHENG Lan,HUANG Li.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.
[9]刘圣英,杨建恩.孕期补钙预防高危孕妇妊娠期高血压疾病的临床观察[J].中国计划生育和妇产科,2012,(03):0.
LIU Sheng-ying,YANG Jian-en.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(8):0.
[10]金爽,尹春艳.IGF-Ⅰ、IGF-Ⅱ、IGFBP-1与妊娠期高血压疾病的相关性研究[J].中国计划生育和妇产科,2012,(05):0.
JIN Shuang,YIN Chun-yan University of South China Teaching Hospital,the Second Peoples Hospital in Guangdong Province,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(8):0.